Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 078 582.4 |
96 | EP file number | EAKZ | 14 71 4794.6 |
86 | WO file number | WAKZ | PCT/IB2014/059627 |
97 | EP publication number | EPN | 2970468 |
87 | WO publication number | WPN | 2014141064 |
54 | Designation/title | TI | NOTCH2-BINDUNGSMOLEKÜLE ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | A61P 11/00 (2006.01) |
22 | DE application date | DAT | Mar 11, 2014 |
96 | EP application date | EAT | Mar 11, 2014 |
86 | WO application date | WAT | Mar 11, 2014 |
43 | Date of first publication | OT | Sep 18, 2014 |
| Date of publication of grant | PET | Jul 7, 2021 |
71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
72 | Inventor | IN | DANAHAY, Henry Luke, Horsham Sussex RH 12 5AB, GB; JAFFE, Aron Brandon, Cambridge, Massachusetts 02139, US |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361866273 P Aug 15, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361779195 P Mar 13, 2013
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002970468 Searchable text:
EP000002970468 Original document:
EP000002970468B1 Searchable text:
EP000002970468B1 Original document:
WO002014141064 Searchable text:
WO002014141064 |
43 | Date of first publication | EVT | Sep 18, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Mar 4, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 22, 2025 (Show all update days)(Hide all update days)- Feb 22, 2025
- Sep 5, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 11.07.2024: changed
- Aug 1, 2024
- Procedures: Opposition procedure, Patent maintained in full by EPO, 11.07.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 11.07.2024: new
- Procedures: Procedure relating to PCT application, Publication of PCT application, 18.09.2014: deleted
- May 9, 2024; Apr 25, 2024; Apr 11, 2024; Feb 24, 2024; Mar 1, 2023; May 26, 2022; Apr 28, 2022; Mar 1, 2022; Jul 29, 2021; Jun 18, 2021; Jun 17, 2021; Sep 20, 2018
- Historical data not available for this/these date(s)
- Mar 4, 2016
- Date of the first transfer into DPMAregister
|